Showing results (121-130 of 169) with videos related to
Sort By:
Pageof 17
Experimental Gerontology|November 30, 2010
The effect of α-actinin-3 deficiency on muscle agingJane T Seto, Stephen Chan, Nigel Turner, et al.ACS Pharmacology & Translational Science|November 15, 2021
Clinical HDAC Inhibitors Are Effective Drugs to Prevent the Entry of SARS-CoV2Ke Liu, Rongfeng Zou, Wenqiang Cui, et al.Nature Communications|November 15, 2017
GyrI-like proteins catalyze cyclopropanoid hydrolysis to confer cellular protectionHua Yuan, Jinru Zhang, Yujuan Cai, et al.Journal of the National Cancer Institute|September 27, 2014
Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancerLawrence Fong, Peter Carroll, Vivian Weinberg, et al.Molecular Microbiology|March 24, 2006
5'-Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in miceRyan H Senaratne, A Dharshan De Silva, Spencer J Williams, et al.Oncogene|March 6, 2021
Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancersReem Ali, Adel Alblihy, Islam M Miligy, et al.Neurology|July 31, 2012
MRI abnormalities following febrile status epilepticus in children: the FEBSTAT studyShlomo Shinnar, Jacqueline A Bello, Stephen Chan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trialJean-Marc Nabholtz, Carla Falkson, Daniel Campos, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2013
AVEREL: a randomized phase III Trial evaluating bevacizumab in combination with docetaxel and trastuzumab as first-line therapy for HER2-positive locally recurrent/metastatic breast cancerLuca Gianni, Gilles H Romieu, Michail Lichinitser, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2005
Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study groupMichel Marty, Francesco Cognetti, Dominique Maraninchi, et al.Pageof 17